Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01456689
Title A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
Novartis Investigative Site Chicago Illinois 60637 United States Details
Novartis Investigative Site Ann Arbor Michigan 48109 United States Details
Novartis Investigative Site Rochester Minnesota 55905 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field